141 related articles for article (PubMed ID: 37011832)
21. Phosphorylation and ubiquitination-dependent degradation of CABIN1 releases p53 for transactivation upon genotoxic stress.
Choi SY; Jang H; Roe JS; Kim ST; Cho EJ; Youn HD
Nucleic Acids Res; 2013 Feb; 41(4):2180-90. PubMed ID: 23303793
[TBL] [Abstract][Full Text] [Related]
22. Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes p53 degradation by stabilizing the E3 ligase MDM2.
Nie J; Xie P; Liu L; Xing G; Chang Z; Yin Y; Tian C; He F; Zhang L
J Biol Chem; 2010 Jul; 285(30):22818-30. PubMed ID: 20484049
[TBL] [Abstract][Full Text] [Related]
23. Mdm2 and MdmX RING Domains Play Distinct Roles in the Regulation of p53 Responses: A Comparative Study of Mdm2 and MdmX RING Domains in U2OS Cells.
Egorova O; Lau HH; McGraphery K; Sheng Y
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075226
[TBL] [Abstract][Full Text] [Related]
24. Ca2+/S100 proteins act as upstream regulators of the chaperone-associated ubiquitin ligase CHIP (C terminus of Hsc70-interacting protein).
Shimamoto S; Kubota Y; Yamaguchi F; Tokumitsu H; Kobayashi R
J Biol Chem; 2013 Mar; 288(10):7158-68. PubMed ID: 23344957
[TBL] [Abstract][Full Text] [Related]
25. The nucleoprotein of influenza A virus induces p53 signaling and apoptosis via attenuation of host ubiquitin ligase RNF43.
Nailwal H; Sharma S; Mayank AK; Lal SK
Cell Death Dis; 2015 May; 6(5):e1768. PubMed ID: 25996295
[TBL] [Abstract][Full Text] [Related]
26. CHIP stabilizes amyloid precursor protein via proteasomal degradation and p53-mediated trans-repression of β-secretase.
Singh AK; Pati U
Aging Cell; 2015 Aug; 14(4):595-604. PubMed ID: 25773675
[TBL] [Abstract][Full Text] [Related]
27. Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase.
Xu C; Fan CD; Wang X
Oncogene; 2015 Jan; 34(3):281-9. PubMed ID: 24413081
[TBL] [Abstract][Full Text] [Related]
28. p53 Ubiquitination and proteasomal degradation.
Love IM; Shi D; Grossman SR
Methods Mol Biol; 2013; 962():63-73. PubMed ID: 23150437
[TBL] [Abstract][Full Text] [Related]
29. Regulation of P53 signaling in breast cancer by the E3 ubiquitin ligase RNF187.
Li X; Niu Z; Sun C; Zhuo S; Yang H; Yang X; Liu Y; Yan C; Li Z; Cao Q; Ji G; Ding Y; Zhuang T; Zhu J
Cell Death Dis; 2022 Feb; 13(2):149. PubMed ID: 35165289
[TBL] [Abstract][Full Text] [Related]
30. XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313.
Lee MG; Han J; Jeong SI; Her NG; Lee JH; Ha TK; Kang MJ; Ryu BK; Chi SG
Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15532-7. PubMed ID: 25313037
[TBL] [Abstract][Full Text] [Related]
31. Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2.
Linares LK; Kiernan R; Triboulet R; Chable-Bessia C; Latreille D; Cuvier O; Lacroix M; Le Cam L; Coux O; Benkirane M
Nat Cell Biol; 2007 Mar; 9(3):331-8. PubMed ID: 17293853
[TBL] [Abstract][Full Text] [Related]
32. Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53.
Rajendra R; Malegaonkar D; Pungaliya P; Marshall H; Rasheed Z; Brownell J; Liu LF; Lutzker S; Saleem A; Rubin EH
J Biol Chem; 2004 Aug; 279(35):36440-4. PubMed ID: 15247280
[TBL] [Abstract][Full Text] [Related]
33. PLAGL2 controls the stability of Pirh2, an E3 ubiquitin ligase for p53.
Zheng G; Ning J; Yang YC
Biochem Biophys Res Commun; 2007 Dec; 364(2):344-50. PubMed ID: 17950244
[TBL] [Abstract][Full Text] [Related]
34. RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage.
Fu X; Yucer N; Liu S; Li M; Yi P; Mu JJ; Yang T; Chu J; Jung SY; O'Malley BW; Gu W; Qin J; Wang Y
Proc Natl Acad Sci U S A; 2010 Mar; 107(10):4579-84. PubMed ID: 20173098
[TBL] [Abstract][Full Text] [Related]
35. SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis.
Li D; Marchenko ND; Moll UM
Cell Death Differ; 2011 Dec; 18(12):1904-13. PubMed ID: 21637290
[TBL] [Abstract][Full Text] [Related]
36. The role of ubiquitination in the direct mitochondrial death program of p53.
Marchenko ND; Moll UM
Cell Cycle; 2007 Jul; 6(14):1718-23. PubMed ID: 17630506
[TBL] [Abstract][Full Text] [Related]
37. Regulation of p53 level by UBE4B in breast cancer.
Zhang Y; Lv Y; Zhang Y; Gao H
PLoS One; 2014; 9(2):e90154. PubMed ID: 24587254
[TBL] [Abstract][Full Text] [Related]
38. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
Asher G; Lotem J; Sachs L; Kahana C; Shaul Y
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13125-30. PubMed ID: 12232053
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of p53 degradation.
Chao CC
Clin Chim Acta; 2015 Jan; 438():139-47. PubMed ID: 25172038
[TBL] [Abstract][Full Text] [Related]
40. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer.
Apostolopoulou K; Pateras IS; Evangelou K; Tsantoulis PK; Liontos M; Kittas C; Tiniakos DG; Kotsinas A; Cordon-Cardo C; Gorgoulis VG
J Pathol; 2007 Nov; 213(3):294-302. PubMed ID: 17907153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
